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Calcitonin is a 32-amino acid thyroid hormone that can form
amyloid fibrils. The structural basis of the fibril formation and
stabilization is still debated and poorly understood. The reason
is that NMR data strongly suggest antiparallel -sheet calci-
tonin assembly, whereas modeling studies on the short DFNKF
peptide (corresponding to the sequence from Asp15 to Phe19 of
human calcitonin and reported as the minimal amyloidogenic
module) show that it assembles with parallel -sheets. In this
work, we first predict the structure of human calcitonin through
two complementary molecular dynamics (MD) methods, find-
ing that human calcitonin forms an -helix. We use extensive
MD simulations to compare previously proposed calcitonin
fibril structures. We find that two conformations, the parallel
arrangement and one of the possible antiparallel structures
(with Asp15 and Phe19 aligned), are highly stable and ordered.
Nonetheless, fibrils with parallel molecules show bulky loops
formed by residues 1 to 7 located on the same side, which could
limit or prevent the formation of larger amyloids. We investi-
gate fibrils formed by the DFNKF peptide by simulating differ-
ent arrangements of this amyloidogenic core sequence. We
show that DFNKF fibrils are highly stable when assembled in
parallel -sheets, whereas they quickly unfold in antiparallel
conformation. Our results indicate that the DFNKF peptide
represents only partially the full-length calcitonin behavior.
Contrary to the full-length polypeptide, in fact, the DFNKF
sequence is not stable in antiparallel conformation, suggesting
that the residue flanking the amyloidogenic peptide contributes
to the stabilization of the experimentally observed antiparallel
-sheet packing.
Amyloid fibrils are protein assemblies often associated to
serious diseases such as Alzheimer’s, Creutzfeldt-Jakob’s, Par-
kinson’s, andmedullary thyroid carcinoma. They are formed by
soluble proteins, which assemble to form insoluble assemblies
that are resistant to degradation. However, amyloid fibrils also
perform a number of physiological roles, such as providing the
core of protective envelopes of fish and insect eggs, essential
amphipathic materials of fungi and bacteria, and a key constit-
uent of spider silk (1).
Despite amyloidogenic proteins do not share all the same
sequences, it has been shown that they share common struc-
tural features, such as the prevalence of -sheet folding, the
presence of a hydrophobic core, and the hierarchical organiza-
tion (2–4). Unfortunately, the insolubility and low crystallinity
of amyloid fibrils hinder the determination of their structures
usingX-ray crystallography andNMR.Nevertheless, themech-
anisms of formation and the structure of amyloid fibrils are
starting to be elucidated (5, 6), also thanks to the contribution of
molecular dynamics (MD)3 simulations (7–9), which allows
investigating the detail of molecular interactions responsible
for fibril initiation and stabilization.
Human calcitonin (hCT) is a thyroid hormone consisting of
32 amino acids and involved in calcium-phosphorous metabo-
lism. In concentrated aqueous solution hCT forms amyloid
fibrils with a diameter of 8 nm, which are associated with med-
ullary carcinoma of the thyroid (10). According to previous
works by the Gazit and co-workers (11), there is strong evi-
dence that the DFNKF peptide (corresponding to residues
ranging from Asp15 to Phe19 of hCT) is the minimal amyloido-
genic unit of calcitonin. Indeed, this peptide quickly self-assem-
bles into highly ordered fibrils and its truncation or mutation
reduce or eliminate fibrillation (12). The fact that DFNKF is
strongly amyloidogenic (but its mutations are not) can explain
the lower amyloidogenic properties of salmon calcitonin (sCT),
the hormone used for the treatment of hypercalcemia or osteo-
porosis, which presents two leucine residues (Leu16 and Leu19)
instead of Phe16 and Phe19 in hCT (Fig. 1) (13).
Despite the solid knowledge on the sequence responsible for
fibril formation and on the effects of pointmutations, the struc-
tural basis of the fibril formation and stabilization is still mostly
unknown. In particular, NMR studies suggested that hCT
forms antiparallel -sheets (14, 15), whereas other studies
based on structural and MD simulations of DFNKF peptides
(16) or crystal structures of halogenated DFNKF peptides (17)
proposed a fibril assembly based on parallel-sheets. However,
these pivotal computational studies, by considering structures
made of a few peptides, do not allow investigating the lateral
interactions that may contribute to hold together several
strands in a fully formed amyloid fibril.
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In this work, we first aim to investigate the conformation of
soluble hCT, for which the experimental structure is lacking.
Second, we modeled for the first time amyloid fibrils with size
comparable with experiments (up to 8 nm in diameter and 15
nm in length) formed either by full-length hCT and, for com-
parison, by DFNKF peptides. These fibril models allow us to
investigate the stability of different proposed assemblies of full-
length calcitonin and DFNKF peptides, so to disclose the likely
structure of calcitonin amyloid fibrils.
Results
Structure of human calcitonin in diluted solutions
We provided the structure of hCT using two different and
complementary approaches, as described under “Materials and
methods.” In the first approach (ab initio), we build the
extended structures of sCT and hCT and then perform 30-ns
replica exchange molecular dynamics (REMD) simulations fol-
lowed by 500-ns classical MD. We validate our protocol by
comparing the structure of sCT predicted with our method
with the one experimentally obtained with NMR (PDB code
2GLH). We first compare the r.m.s. deviation of our model
using the NMR structure as a reference, during REMD simula-
tion and during classical MD (see supplemental Fig. S1). The
results show that r.m.s. deviation quickly decrease during the
REMDsimulation as calcitonin gradually forms an-helix from
residue 4 to 21, in agreement with the experimental structure.
In the following MD simulation, the structure is highly stable,
as shown by the small oscillation in r.m.s. deviation values. We
compare the evolution of the helical content during REMD and
MD simulations. The -helix quickly develops during REMD
and it stabilizes during the MD simulation (Fig. 2). In the last
part of the MD simulation, the helix stably involves residues
5–19 and it often extends from residue 4 to 21, in high agree-
ment with the experimental structure. It is important to note
that the NMR structure is composed of 100 different confor-
mations, which differ for the extension of the -helix (variably
terminating between residues 20 to 22) and for the arrange-
ment of the disposition of coil termini.Overall, our results show
a good agreement between the predicted and the experimental
sCT structure (Fig. 4A), which ismade of a long-helix (residue
4–21) and a random coil C terminus.
The same protocol coupling REMD and classical MD is then
applied to predict the structure of hCT. To assess the conver-
gence of the simulations we monitor the polypeptide r.m.s.
deviation using the sCT NMR structure as a reference. The
results show that r.m.s. deviation quickly decreases during the
REMD simulation as hCT gradually forms an -helix and then
stabilized during the MD simulation. Starting from the
extended conformation, the REMD simulation results in an
extended -helix covering residues 5–14. In the following,
500-ns long classical MD simulation in explicit solvent the
-helix became more continuous including all residues in the
range 4 to 19 (Fig. 3). The secondary structure timeline shows
that despite the difference in primary sequence between, the
structure adopted by hCT is very similar to that of sCT (r.m.s.
deviation  3.3  0.18 Å) with -helix as dominant motif for
the secondary structure and covering residues 4–19 (Fig. 4B).
As a further validation of the predicted hCT structure, we
used a homology modeling approach based on the sCT struc-
ture. In the initial homology model the helix covers residues
4–21 (as in the PBD code 2GLH template), whereas after MD
the helix stabilize in the 5–19 range, the same range obtained
with the ab initio protocol. The r.m.s. deviation difference in
the helical section between the two predicted hCT structures is
0.47 0.37Å,which further confirms that the two independent
methods yield the same hCT structure. The PDB structure of
the final hCT model is available in the supplemental figures.
Human calcitonin amyloid conformation
We investigated the likelihood of three previously proposed
conformations of calcitonin amyloid fibrils.We first considered
calcitonin octamers to assess the stability of fibril nucleation
sites and subsequently we tested protofibrils made of 32 calci-
tonin molecules to test the influence of lateral interactions.
All three octamer models reach structural equilibrium
within 100 ns of simulation, thuswe use the remaining 100 ns of
simulation as production run to average quantitative results. In
particular, the r.m.s. deviation is highly stable for all three con-
formations with fluctuations of less than 1 Å (see supplemental
Fig. S2). The stable structures of hCT octamers are shown in
Fig. 5. We observe that the parallel octamer forms a clear bend
in themiddle of the polypeptide chain, which could prevent the
lateral aggregation of further calcitonin molecules. On the
other hand, in both of the antiparallel octamers the polypeptide
molecules maintain a straight conformation and assume a
super-helical twist, which is compatible with experimental
observation of helical fibrils.
For all three octamers,we analyzed the content of the-sheet
secondary motif during MD simulations (Fig. 6A). The -sheet
content stabilizes to 40.5  1.8% for the parallel octamer, to
46.0  2.4% for the antiparallel 1 model, and to 40.0  1.9 for
the antiparallel 2 model. The antiparallel 1 model thus presents
the highest content of amino acid forming -sheets, suggesting
that this conformation is slightlymore stable than the two other
proposed models, in accordance with previous NMR results
(13). To test the stability of each system we performed 100-ns
long simulations at increasing temperatures (from 350 to 450
K), showing a decrease of the -sheet content for all models
(Fig. 6B). The results show that the -sheet content decreases
with the temperature for all systems, however, there is a clear
drop at specific temperatures, which are different depending on
the models, suggesting that the stability follows the order par-
allel antiparallel 1 antiparallel 2.
In addition to the octamers (representing nucleation sites),
we investigate the stability of small hCT amyloid fibrils (proto-
fibrils), constituted of four hCT octamers (i.e. 32 hCT mole-
cules). All three systems reach r.m.s. deviation convergence
within 80 ns of MD. The results show that antiparallel 1
Figure 1. Calcitonin sequence alignment. Human and salmon calcitonins
are aligned using ClustalW 1.82 (38). Asterisks denote identity, dots indicate
similarity, and no marks denote very different residues. Despite the high ho-
mology (50% identity, 87.5% similarity) the salmon calcitonin is much less
amyloidogenic. In particular, the amyloid-forming sequence in hCT (red) is
rather different in the salmon calcitonin (blue).
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arrangement presents a larger content of residues in the
-sheet conformation. In particular, during the last 20 ns ofMD
simulations, the -sheet content is 24.45  0.74% for the par-
allel arrangement, 30.5  0.78% for antiparallel 1, and 21.7 
0.75% for antiparallel 2 model.
The stability and the -sheet content in the protofibrils is
investigated also with Simulated Annealing, in which the mod-
els are rapidly heated to 500 K and cooled down to 300 K. In all
models the -sheet content rapidly decreases during the heat-
ing phase and remains stable during the cooling-down phase.
The lost secondary structure motifs are not recovered during
the third phase of the simulation (stable at 300 K for 100 ns).
However, the antiparallel 1 and parallel conformations keep a
comparable -sheet content of 20%, thus confirming these
two structures as possible calcitonin amyloid conformations,
whereas the antiparallel 2 show a lower degree of ordered sec-
ondary structures (Fig. 7). We note that whereas the -sheets
involve the central part of the antiparallel 1 protofibril, in the
parallel conformation the -sheet content is located mostly in
theC-terminal part of themolecules. This behavior is due to the
bulky loop located in the N-terminal region and formed by res-
idues 1–7 (linked by the Cys1-Cys7 disulfide bridge) that in the
parallel model are located on the same side. This disordered
region, although is not destabilizing in the protofibril models
considered here, could limit the assembly and/or growth of
larger hCT fibril.
DFNKF amyloid peptides
To assess possible differences in the amyloids formed by full-
length hCT and the minimal fibril forming peptide DFNKF, we
investigate the stability of DFNKF octamers in parallel and in
antiparallel conformations. For this purpose the peptides are
stacked and then simulated for 100 ns in explicit water. The
results clearly show that the parallel arrangement is extremely
stable, as it forms a supramolecular helix that is retained for the
Figure 2. Secondary structure of salmon calcitonin during REMD andMD simulations. Salmon calcitonin amino acids are listed along the y axis and their
secondary structure time evolution is represented along the x axis. Pink represents  helical conformation.
Figure 3. Secondary structure of human calcitonin during REMD andMD simulations.Human calcitonin amino acids are listed along the y axis and their
secondary structure time evolution is represented along the x axis. Pink represents  helical conformation.
Figure 4. Structural alignment of final MDmodels and NMR structure. In
yellow, the PDB code 2GLHexperimental structure of sCT; in cyan, the ab initio
predicted structure of sCT, at the end of the 500-ns MD simulations (panel A),
showing excellent agreement. Panel B shows the predicted hCT structure at
the end of a 500-ns longMD simulation (blue) that exhibits an extended helix
ranging from residue 5 to 19. Yellow represents the experimental sCT struc-
ture for comparison.
Figure 5. Conformations of the different hCT octamers. The stable struc-
ture of the three putative arrangements of hCT amyloids after 200-ns long
classical MD simulation at 300 K.
Nanostructure and stability of calcitonin amyloids
7350 J. Biol. Chem. (2017) 292(18) 7348–7357










whole simulated time. Conversely, the octamer in antiparallel
arrangement quickly breaks apart in a few nanoseconds (Fig. 8).
Both arrangements allow for the formation of inter-strand
hydrogen bonds that stabilize the structures. However, only the
parallel conformation allows for the occurrence of aromatic
ring stacking of phenylalanine residues in positions 2 and 5,
which significantly contribute to the overall stability of the
fibril.
It has been previously suggested that-sheets oligomers rep-
resent the nucleation core of the amyloid fibrils during their
formation (12). Here we show that the oligomers are not sta-
ble in the antiparallel configuration, hence the nucleation
and thus the formation of fibrils will be unlikely. Conversely,
the oligomers with parallel peptides show large stability,
thus suggesting a higher potential to be the nucleation core
of DFNKF fibril. However, to rule out the possibility that
lateral interactions stabilize the antiparallel -sheets, we
investigated 72-mer DFNKF protofibrils using all possible
configurations in the three directions, leading to eight dif-
ferent protofibrils (Fig. 9).
The results show that the stability (in terms of secondary
structure content) at room temperature is higher for models
that have a parallel arrangement in lateral direction (Direction
2), whereas the configuration in the other two directions has a
limited effect in the stability (Fig. 10A). To further assess the
stability of the systems, we simulated the four most stable sys-
Figure 6. -Sheet in hCT octamers during MD simulations. The -sheet motif content for each octamer model is represented during the 200-ns MD
simulations (A). The trends for the two antiparallel conformations are highly comparable, although the -sheet content is slightly higher in the parallel
arrangement. The thermal stability differs for the threemodels (B), showing that at 400Konly theparallel hCToctamers retains a significant contentof-sheets.
The -sheet content is the average after it reaches a stable value during the MD simulations at the different temperatures (300, 350, 375, 400, and 450 K).
Figure 7. -Sheet content and structures of the different hCT protofibrils. The variation of -sheet content during the 100-ns MD simulation at 300 K (A)
and during the Simulated AnnealingMD simulation (B), showing that antiparallel 1 conformation has the highest degree of-sheet organization, whereas the
parallel arrangement is the most resistant to thermal stress. The stable structures of the three protofibrils are shown on the right.
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tems (A-P-HT, A-P-HH, P-P-HT, and P-P-HH) at 7 different
fixed temperatures ranging from 300 to 450K for 100 ns at each
temperature.
The analysis of -sheet content during simulations at
increasing temperatures (Fig. 10B) shows that models with a
parallel arrangement in Direction 1 (fibril axis) keep a higher
content of secondary motifs during the heating process com-
pared with antiparallel configuration in the same direction.
These results show that the most stable protofibrils are those
with parallel configuration in Direction 1 and Direction 2, with
limited effect of the orientation in Direction 3 (i.e. P-P-HH and
P-P-HT).
The extremely stable and ordered structure of the protofi-
brils allows us a deeper insight into the different stabilizing
molecular interactions. The in-depth analysis of interactions is
performed on the P-P-HT protofibril, being the most stable.
The peptides are connected by up to five highly stable hydrogen
bonds (observed for 30% of simulated time) (Fig. 11A). The
assembly is further stabilized by aromatic ring stacking of Phe2
and Phe5 residues (Fig. 11B). The two phenylalanine side
chains, together with the alkane chain of Lys4, contribute to
the formation of the tight hydrophobic core of the amyloid
fibrils, which is responsible for the lateral inter-strand stabi-
lization of the fibril (Fig. 11, C and D). Finally, a network of
highly stable salt bridges (observed for 70% of simulated
time) is responsible for the head-to-tail connectivity be-
tween strands (Fig. 11E).
Figure 8. Antiparallel and parallel conformations. The antiparallel conformation (A) quickly results in the disruption of the octamer (B). The parallel
arrangement of-sheet (C) leads instead to the formationof a stable supramolecular helix that lasts for thewholeMDsimulation (D). Theparallel conformation
is stabilized by inter-strand hydrogen bonds (also found in the antiparallel conformation) and by aromatic interactions (- stacking) involving phenylalanine
residues in positions 2 and 5. These hydrophobic interactions are not observed in the antiparallel arrangement.
Figure9.Molecularmodels ofDFNKFprotofibrils.Protofibrilsmadeof 8
3 3 pentapeptides (A) are assembled combining all possible configurations
in the three directions, leading to 8 different protofibril models (B). The nam-
ing of different protofibrils is Direction 1-Direction 2-Direction 3 (where A,
antiparallel;P, parallel;HT, head-to-tail;HH, head-to-head). For example, “A-A-
HH” is theprotofibrilwith antiparallel configuration inDirection1, antiparallel
configuration in Direction 2, and head-to-head configuration in Direction 3.
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We first investigated the structure of the calcitonin mono-
mer because it is the building block of the calcitonin amyloids
and, although it has been suggested that the monomer confor-
mation has predominant -helix content (similar to salmon
calcitonin), its secondary structure has never been fully charac-
terized by X-ray or NMR. Here, by modeling the single mono-
mer (starting froman extended configuration)we show that the
isolated monomer spontaneously folds as an -helix. On
the other hand, the presence of multiple monomers stabilize
the extended conformation, leading to the formation of the
amyloid fibril.
A major open question concerning calcitonin fibrils involve
the apparent discrepancy between NMR data on full-length
hCT showing the prevalence of antiparallel -sheets (14) and
computational and structural studies of DFNKF peptides pro-
posing a fibril assembly based on parallel-sheets (16). Herewe
show that although DFNKF peptides are able to form stable
fibrils only with parallel assembly, the full-length polypeptide
forms amyloid structures both with parallel and antiparallel
arrangements. The different stability of antiparallel conforma-
tions in DFNKF and hCTmay be explained taking into account
stabilizing interactions that involve residues flanking the
DFNKF sequence in hCT. The analysis of hCT octamers and
protofibrils in antiparallel 1 conformation highlights the pres-
ence of four highly stable (50% of simulation time) intermo-
lecular H-bonds that contribute to amyloid stabilization. These
interactions involve residues Tyr12-His20, Thr21-Thr13, Gln14-
His20, Thr21-Thr12 (Fig. 12). The lack of these interactions
when only the DFNKF sequence is considered may explain the
different behaviors between the pentapeptide and full-length
calcitonin.
Figure10.-Sheet contentofDFNKFprotofibrils.Theprotofibrilswith aparallel configuration in the lateral direction (X-P-X) showhigher stability compared
with all the other as observed during 100-ns simulations at room temperature (A). Simulations at increasing temperature show that the protofibrils with a
parallel configuration in the fibril direction (i.e. P-P-X) show higher stability compared with the antiparallel configuration in the same direction. We excluded
from this analysis the protofibrils with lateral antiparallel arrangement in (X-A-X) because they are unstable already at room temperature (B). The -sheet
content is averaged over all 72 pentamer at each time point. We note that the secondary structure analysis does not include the two terminal residues of the
pentamer, hence the maximum -sheet content is 60%.
Figure 11. Amyloid stabilizing interactions. The DFNKF peptides are held together by intra-strand hydrogen bonds: four of these hydrogen bonds involve
backbone-backbone interactions, where an additional hydrogen bond is observed between the side chains of stacked Asn3 residues (A). Further stabilization
is provided by aromatic ring stacking of Phe residues (B). Lateral connections betweenDFNKF strands are due to hydrophobic interactions that involve, on one
side, the aromatic ring of Phe2 and the alkane chain of Lys4 and, on the other side, the aromatic ring of Phe5 (C). The tight lateral interconnection between
DFNKF strands defines the hydrophobic core of the amyloid fibril, from which the water molecules (red dots) are excluded (D). The head-to-tail connection
between the strands is provided by salt bridges (up to 5 different types) involving the N-terminal (), the C-terminal (), Lys4 side (), and Asp1 side chain ()
(E). This highly hydrophilic region is also where the totality of water molecules are located within the fibril.
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On the other hand, we observe that full-length hCT present
stable structures with parallel -sheets, which are not observed
in experiments. Nonetheless, despite the high stability, the
models of the nucleation core (octamers) assembled with par-
allel -sheets present a marked bend in the central part of the
octamer, which could prevent or delay lateral aggregation. The
protofibril models with parallel molecules show that -sheets
involve only the C-terminal section of themolecule because the
bulky loops formed by residues 1 to 7 are located on the same
side (Fig. 13). Although this phenomenon does not disrupt the
protofibrils considered here, it can hinder the aggregation or
extension of larger fibrils. Hence, although we cannot rule out
the possibility of hCT forming parallel -sheets, there is evi-
dence for a preferential aggregation with the antiparallel
conformation.
Conclusions
Diluted human calcitonin forms an-helix
The first major finding of this work is the structure of the
soluble hCT, which was previously unavailable, showing that it
is made of a continuous helix ranging from residue 5 to 19, a
structure very similar to that of sCT. The same hCT structure is
obtained with two independent methods, ab initio folding
based on REMD and homology modeling, showing the high
reliability of the proposed structure.
Human calcitonin forms amyloid fibrils in antiparallel
conformation
We showed that full-length hCT arranges as amyloid fibril
preferably as an antiparallel conformation with Asp15 and
Phe19 aligned. This structure provide the highest content of
-sheets motif at room temperature and it is the conformation
proposed in previous NMR studies, which reported that this
conformation accounts for 70% of hCT amyloids (14). A further
finding of this work is that hCT behaves differently from
DFNKF peptides, which assemble only in parallel-sheets. Our
MD simulations show that antiparallel assembly quickly
unfolds, whereas parallel -sheets hold the structure for the
whole 100-ns simulation. This finding confirms the results of
previous work on DFNKF peptides (16), in which MD simula-
tions up to 4 ns suggested a parallel assembly. The results
shownhere thus provides evidence that the full-length hCTand
theDFNKF peptidemay assemble in a different way, explaining
the apparent discrepancy betweenNMRdata and previousMD
results.
The detailed knowledge of hCT assembly and the molecular
model developed here may help to better understand and pro-
vide a solution against amyloid formation (18). For example, a
recent study found evidence that molecules such as magnolol
and honokiol have inhibitory effects of hCT aggregation (19).
Our models can be used to investigate the detailed interactions
of these molecules with hCT fibrils and provide the basis for
further drug optimization. Similarly, the insights into DFNKF
peptides assembly can be crucial for nanobiotechnological
applications (20–22), thanks to the possibility to tune their
properties, for example, by halogenation (23) or site-specific
functionalization (24).
Materials andmethods
Structure of human calcitonin in diluted solutions
We investigated the structure of soluble hCT with two com-
plementary approaches. In the first method (ab initio), we
started from the extended structure and used REMD simula-
tion followed by extensive MD simulation. The protocol is val-
idated by testing on sCT, for which the folded structure is
known (Protein Data Bank code 2GLH). In the second method
(homology modeling), we used the structure of sCT as a tem-
plate to generate the initial folding of hCT, then the hCTmodel
is extensively equilibrated. Finally, we compared the structures
obtained with the two independent methods.
For the ab initio method we built the starting (extended)
conformations of both sCT and hCT using PyMol (25). The
disulfide bond between cysteines residues in positions 1 and 7 is
included during topology building, thenweminimize the struc-
ture while applying a position restrain (with a 1 kcal mol1 Å2
spring constant) to the backbone of residues from 12 to 32, to
allow the relaxation of the disulfide bond. To obtain an accurate
folded structure of hCT in solution we perform REMD (26)
followed by extensive classicMD simulation in explicit solvent.
We validated our protocol using sCTwhose three-dimensional
crystallized structure is available in the ProteinData Bank (PDB
code 2GLH) (27). Starting from the initial extended model of
Figure 12. Hydrogen bonds among calcitonin residues not included in
DFNKF sequence. A–D, four highly stable hydrogen bonds formed in the
region excluded byDFNKF peptides (highlighted in red) may explain the abil-
ity of full-length hCT to assemble as antiparallel -sheets, which is precluded
to DFNKF alone.
Figure13.N-terminal loops.The figure shows the initial packingof aparallel
octamer, highlighting how the bulky loops (inset) on the same side may
destabilize the fibrils. The simulation of small protofibrils shows that,
although the amyloid structure is stable, the -sheets are located only in the
C-terminal section, whereas the N-terminal region is highly disordered. This
behavior could limit or prevent the formation of larger amyloid with parallel
arrangement of hCT molecules.
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both polypeptides, we ran 30-ns REMD simulations using
NAMD code (28) and CHARMM22 force field with C-map
correction (29) in a vacuum with a temperature range between
300 and 500K. From the trajectories, we extracted the frames at
300 K and clusterized hCT and sCT conformations with the
VMD clustering tool (with 1.0-Å cutoff and restricting analysis
to amino acids from 4 to 23 to avoid taking in account floppy
terminals). For both sCT and hCT we selected one frame from
the most populated conformational cluster and solvated the
polypeptide using the TIP3P explicit solvent model (30) and
add ions to neutralize the system. The setup resulted in a
63,000 atom system in a simulation box of initial dimensions
95 87 80 Å3. The system was minimized and equilibrated
using the NAMD code (28) under constant pressure and tem-
perature (NPT) conditions to relax the volume of the periodic
box. The pressure was set to 1 atm and the temperature to 300
K,whereas using a time step of 2 fs, a non-bonded cut-off of 9Å,
rigid bonds, and particle-mesh Ewald long-range electrostatics.
Subsequently, we performed 500-ns long MD simulations at
300K to stabilize the structure in explicit solvent.We employed
ACEMD (31) on a NVIDIA Kepler K40 GPU using a time step
of 4 fs, and a NVT ensemble. All other parameters (tempera-
ture, non-bonded cut-off, and PME) are the same as in the
equilibration phase.We evaluated the stability of the systems by
monitoring the convergence of the r.m.s. deviation in VMD
(32) software.
To confirm the structure of hCT obtained with the ab initio
method, we built a new structure using homology modeling
based on the sCT structure. We used Modeler software (33),
building 500 models and choosing the best result according to
DOPE score. We then simulated the resulting polypeptide for
200 ns in explicit solvent using ACEMD software. All MD
parameters were kept the same as discussed above and the
structure was analyzed (after r.m.s. deviation convergence) in
terms of secondary structure stability and extension.
Human calcitonin amyloid conformation
To elucidate the structure of hCT amyloid we first investi-
gated hCT octamers in three different conformations, because
the formation of-strands has been proposed as the first step in
amyloid nucleation (12). On the basis of NMR studies, Naito
and colleagues (13) proposed two antiparallel packing confor-
mations that differ for displacement along the polypeptide axis.
In addition to these two packing conformations, we tested the
stability of the parallel arrangement, based on previous works
(14), suggesting that DFNKF peptides assemble in parallel con-
formation (Table 1, models 1, 2, 3). The initial assembly in the
form of parallel or antiparallel -sheets is performed in VMD
(32). The single monomer in extended configuration is aligned
along the x axis, then wemake 7 copies of themonomer and we
displace the copies along the y axis by multiples of 5 Å. The
distance is chosen to avoid atom clashing but at the same time
allowing the formation of intermolecular interactions and thus
avoiding the separation of the chains. A similar distance has
been used in the past to model assembly of DFNKF peptides
(16). In the case of antiparallel octamers, every second mono-
Table 1
Molecular models of calcitonin amyloid fibrils
Three different calcitonin octamers are employed to test the likelihood of three different proposed amyloid structures (antiparallel 1, antiparallel 2, parallel). The octamers
are then assembled in protofibrils, to tests the influence of lateral interactions.
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mer is rotated by 180° around the y axis and displaced according
to NMR studies (13) (see also Table 1). We then minimize the
structure while applying a position restrain to the backbone of
residues from 12 to 32, to allow the relaxation of the disulfide
bond between Cys1 and Cys7. The systems were then solvated
with TIP3P water molecules in a periodic box. The molecular
models are minimized and equilibrated following protocols
used in previous studies (34–36). Briefly, we use NAMD code
(28) under constant pressure and temperature (NPT) condi-
tions to relax the volume of the periodic box. The pressure was
set to 1 atm and the temperature to 300 K, while using a time
step of 2 fs, a non-bonded cut-off of 9 Å, rigid bonds, and par-
ticle-mesh Ewald long-range electrostatics. During minimiza-
tion andNPT equilibration, theC atoms of residues from12 to
32 are restrained by a 1 kcalmol1 Å2 spring constant. Finally,
the production run is performed using ACEMD (31) on a
NVIDIAKepler K40GPU for 200 ns. In addition, each system is
simulated for 100 ns at temperatures of 350, 375, 400, and 450K
to test the temperature-dependent stability of the three differ-
ent conformations. All the analyses are conducted after r.m.s.
deviation convergence.
To test the influence of lateral interactions, we built three
different protofibrils, one for each octamer conformation
(Table 1). The protofibril models were obtained by duplicating
the octamers and translating them by 10 Å along the z axis.
Hence, each protofibril includes four octamers for a total of 32
hCT molecules. To test the stability of the different amyloid
conformations, we performed 100-ns long classical MD simu-
lations at the stable temperature of 300 K. In addition, we per-
formed simulated annealingMD simulations in which the tem-
perature increases from 300 to 500K (5K every 0.5 ns), then the
systems are cooled down at the same rate and finally simulated
at 300 K for 100 ns.
DFNKF amyloid peptides
The initial structure of theDFNKFpeptide is generated using
PyMol (25). The initial assembly (octamers) in the form of par-
allel or antiparallel -sheets is performed in VMD (32). The
single peptide is aligned along the x axis, then wemake 7 copies
of the monomer and displace the copies along the y axis by
multiples of 5 Å. Larger assemblies (protofibrils) were obtained
by duplicating the -sheets and displacing them by 10 Å (and
multiples) along Direction 2 and by 20 Å (and multiples) along
Direction 3 (see Fig. 9 and Table 2). Distances are chosen to
allow close packing without excessive atom clashing.
The octamers corresponds to assemblies similar to those
studied in previous works (16, 37) and aremeant to evaluate the
stability of parallel and antiparallel configuration of the nucle-
ation core. Protofibrils are investigated in all possible configu-
rations using 72-mer protofibrils made of 8  3  3 DFNKF
peptides. We thus investigated the 8 different protofibrils aris-
ing by combining the two possible configurations for each of
the three directions (Fig. 9B).
The systems were solvated with TIP3P water molecules in a
periodic box (with size depending on the amyloid dimensions).
The systems were equilibrated using the same protocol
described for the full-length calcitonin amyloid models. The
stability (measured as -sheets content) of the eight different
assemblieswas assessed through 100-ns long simulations at 300
K. For themost stable conformations we further investigate the
stability by running simulations at increasing temperature up to
450 K. All analyses (e.g. hydrogen bonds, salt bridges, helix pe-
riodicity) are conducted using the VMD software package (32)
and tcl scripting.
Author contributions—P. M., A. R., and A. G. designed the research.
F. R. andA. G. implemented themodel and analysis tools, carried out
the simulations, and collected the data. F. R., A. R., P. M., and A. G.
analyzed the data and wrote the paper.
References
1. Hauser, C. A., Maurer-Stroh, S., and Martins, I. C. (2014) Amyloid-based
nanosensors and nanodevices. Chem. Soc. Rev. 43, 5326–5345
2. Rambaran, R. N., and Serpell, L. C. (2008) Amyloid fibrils: abnormal pro-
tein assembly. Prion 2, 112–117
3. Caplan, M. R., Moore, P. N., Zhang, S., Kamm, R. D., and Lauffenburger,
D. A. (2000) Self-assembly of a beta-sheet protein governed by relief of
electrostatic repulsion relative to van derWaals attraction. Biomacromol-
ecules 1, 627–631
4. Hong, Y., Legge, R. L., Zhang, S., and Chen, P. (2003) Effect of amino acid
sequence and pH on nanofiber formation of self-assembling peptides
EAK16-II and EAK16-IV. Biomacromolecules 4, 1433–1442
5. Petkova, A. T., Ishii, Y., Balbach, J. J., Antzutkin, O. N., Leapman, R. D.,
Delaglio, F., and Tycko, R. (2002) A structural model for Alzheimer’s
-amyloid fibrils based on experimental constraints from solid state
NMR. Proc. Natl. Acad. Sci. U.S.A. 99, 16742–16747
6. Jaroniec, C. P., MacPhee, C. E., Bajaj, V. S., McMahon, M. T., Dobson,
C. M., and Griffin, R. G. (2004) High-resolution molecular structure of a
peptide in an amyloid fibril determined by magic angle spinning NMR
spectroscopy. Proc. Natl. Acad. Sci. 101, 711–716
7. Ma, B., and Nussinov, R. (2002) Stabilities and conformations of Alzhei-
mer’s-amyloid peptide oligomers (A16–22, A16–35, andA10–35):
sequence effects. Proc. Natl. Acad. Sci. U.S.A. 99, 14126–14131
8. Nguyen, H. D., and Hall, C. K. (2004) Molecular dynamics simulations of
spontaneous fibril formation by random-coil peptides. Proc. Natl. Acad.
Sci. U.S.A. 101, 16180–16185
9. Urbanc, B., Cruz, L., Yun, S., Buldyrev, S. V., Bitan, G., Teplow, D. B., and
Stanley, H. E. (2004) In silico study of amyloid -protein folding and olig-
omerization. Proc. Natl. Acad. Sci. U.S.A. 101, 17345–17350
10. Arvinte, T., Cudd, A., and Drake, A. F. (1993) The structure and mech-
anism of formation of human calcitonin fibrils. J. Biol. Chem. 268,
6415–6422
Table 2
Molecular models of DFNKF amyloid fibrils
Octamer models are used to test the preference for parallel or antiparallel nucle-
ation. The full analysis of stabilizing interactions (longitudinal, lateral, and head-to-
tail) is performed on protofibril model.
Nanostructure and stability of calcitonin amyloids
7356 J. Biol. Chem. (2017) 292(18) 7348–7357










11. Reches, M., Porat, Y., and Gazit, E. (2002) Amyloid fibril formation by
pentapeptide and tetrapeptide fragments of human calcitonin. J. Biol.
Chem. 277, 35475–35480
12. Tsai, H.-H. Reches, M., Tsai, C.-J., Gunasekaran, K., Gazit, E., and Nussi-
nov, R. (2005) Energy landscape of amyloidogenic peptide oligomerization
by parallel-tempering molecular dynamics simulation: significant role of
Asn ladder. Proc. Natl. Acad. Sci. U.S.A. 102, 8174–8179
13. Itoh-Watanabe, H., Kamihira-Ishijima, M., Javkhlantugs, N., Inoue, R.,
Itoh, Y., Endo, H., Tuzi, S., Saitoˆ, H., Ueda, K., and Naito, A. (2013) Role of
aromatic residues in amyloid fibril formation of human calcitonin by sol-
id-state 13CNMRandmolecular dynamics simulation.Phys. Chem. Chem.
Phys. 15, 8890–8901
14. Naito, A., Kamihira,M., Inoue, R., and Saitoˆ, H. (2004) Structural diversity
of amyloid fibril formed in human calcitonin as revealed by site-directed
13C solid-state NMR spectroscopy.Magn. Reson. Chem. 42, 247–257
15. Kamihira, M., Oshiro, Y., Tuzi, S., Nosaka, A. Y., Saitoˆ, H., and Naito, A.
(2003) Effect of electrostatic interaction on fibril formation of human
calcitonin as studied by high resolution solid state 13CNMR. J. Biol. Chem.
278, 2859–2865
16. Haspel, N., Zanuy, D., Ma, B., Wolfson, H., and Nussinov, R. (2005) A
comparative study of amyloid fibril formation by residues 15–19 of the
human calcitonin hormone: a single -sheet model with a small hydro-
phobic core. J. Mol. Biol. 345, 1213–1227
17. Bertolani, A., Pizzi, A., Pirrie, L., Gazzera, L., Morra, G., Meli, M., Co-
lombo, G., Genoni, A., Cavallo, G., Terraneo, G., and Metrangolo, P.
(2016) Crystal structure of the DFNKF segment of human calcitonin
unveils aromatic interactions between phenylalanines. Chemistry 23,
2051–2058
18. Andreotti, G., Vitale, R. M., Avidan-Shpalter, C., Amodeo, P., Gazit, E., and
Motta, A. (2011) Converting the highly amyloidogenic human calci-
tonin into a powerful fibril inhibitor by three-dimensional structure
homology with a non-amyloidogenic analogue. J. Biol. Chem. 286,
2707–2718
19. Guo, C., Ma, L., Zhao, Y., Peng, A., Cheng, B., Zhou, Q., Zheng, L., and
Huang, K. (2015) Inhibitory effects of magnolol and honokiol on human
calcitonin aggregation. Sci. Rep. 5, 13556
20. Reches, M., and Gazit, E. (2006) Controlled patterning of aligned self-
assembled peptide nanotubes. Nat. Nanotechnol. 1, 195–200
21. Reches, M., and Gazit, E. (2005) Self-assembly of peptide nanotubes and
amyloid-like structures by charged-termini-capped diphenylalanine pep-
tide analogues. Isr. J. Chem. 45, 363–371
22. Du, A. W., and Stenzel, M. H. (2014) Drug carriers for the delivery of
therapeutic peptides. Biomacromolecules 15, 1097–1114
23. Bertolani, A., Pirrie, L., Stefan, L., Houbenov,N.,Haataja, J. S., Catalano, L.,
Terraneo, G., Giancane, G., Valli, L., Milani, R., Ikkala, O., Resnati, G., and
Metrangolo, P. (2015) Supramolecular amplification of amyloid self-as-
sembly by iodination. Nat. Commun. 6, 7574
24. Fichman, G., Guterman, T., Adler-Abramovich, L., and Gazit, E. (2014)
The use of the calcitonin minimal recognition module for the design of
DOPA-containing fibrillar assemblies. Nanomaterials 4, 726–740
25. Schro¨dinger L. L. C. (2015) The PyMOLMolecular Graphics System, ver-
sion	1.8, Schroedinger, LLC, New York
26. Sugita, Y., and Okamoto, Y. (1999) Replica-exchange molecular dynamics
method for protein folding. Chem. Phys. Lett. 314, 141–151
27. Andreotti, G., Me´ndez, B. L., Amodeo, P., Morelli, M. A., Nakamuta, H.,
andMotta, A. (2006) Structural determinants of salmon calcitonin bioac-
tivity: the role of the Leu-based amphipathic -helix. J. Biol. Chem. 281,
24193–24203
28. Nelson, M. T., Humphrey, W., Gursoy, A., Dalke, A., Kale, L. V.,
Skeel, R. D., and Schulten, K. (1996) NAMD: a parallel, object oriented
molecular dynamics program. Int. J. High Perform. Comput. Appl. 10,
251–268
29. Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S.,
Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., and Mackerell,
A. D. (2010) CHARMM general force field: a force field for drug-like
molecules compatible with the CHARMM all-atom additive biological
force fields. J. Comput. Chem. 31, 671–690
30. Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., and
Klein, M. L. (1983) Comparison of simple potential functions for simulat-
ing liquid water. J. Chem. Phys. 79, 926
31. Harvey, M. J., Giupponi, G., and Fabritiis, G. D. (2009) ACEMD: acceler-
ating biomolecular dynamics in themicrosecond time scale. J. Chem. The-
ory Comput. 5, 1632–1639
32. Humphrey,W., Dalke, A., and Schulten, K. (1996) VMD: visual molecular
dynamics. J. Mol. Graph. 14, 33–38, 27–8
33. Fiser, A., and Sali, A. (2003) MODELLER: Generation and refinement of
homology-based protein structure models. Methods Enzymol. 374,
461–491
34. Gautieri, A., Redaelli, A., Buehler, M. J., and Vesentini, S. (2014) Age- and
diabetes-related nonenzymatic crosslinks in collagen fibrils: candidate
amino acids involved in advanced glycation end-products. Matrix Biol.
34, 89–95
35. Gautieri, A., Vesentini, S., and Redaelli, A. (2010) How to predict diffusion
of medium-sizedmolecules in polymermatrices: from atomistic to coarse
grain simulations. J. Mol. Model. 16, 1845–1851
36. Nair, A. K., Gautieri, A., and Buehler, M. J. (2014) Role of intrafibrillar
collagen mineralization in defining the compressive properties of nascent
bone. Biomacromolecules 15, 2494–2500
37. Tsai, H.-H., Zanuy, D., Haspel, N., Gunasekaran, K.,Ma, B., Tsai, C.-J., and
Nussinov, R. (2004) The stability and dynamics of the human calcitonin
amyloid peptide DFNKF. Biophys. J. 87, 146–158
38. Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan,
P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R.,
Thompson, J. D., Gibson, T. J., and Higgins, D. G. (2007) Clustal W and
Clustal X version 2.0. Bioinformatics. 23, 2947–2948
Nanostructure and stability of calcitonin amyloids
J. Biol. Chem. (2017) 292(18) 7348–7357 7357










Federica Rigoldi, Pierangelo Metrangolo, Alberto Redaelli and Alfonso Gautieri
Nanostructure and stability of calcitonin amyloids
doi: 10.1074/jbc.M116.770271 originally published online March 10, 2017
2017, 292:7348-7357.J. Biol. Chem. 
  
 10.1074/jbc.M116.770271Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  






This article cites 37 references, 12 of which can be accessed free at
 by guest on M
ay 10, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
